Impact of a Sequential Isokinetic Fatigue Protocol Followed by Ankle Strengthening After Botulinum Toxin Injection Into Spastic Plantar Flexors on Foot Lift Strength and Walking
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 主要终点
- Strength of the foot lifters
研究概览
简要总结
Spastic foot drop (speed- and force-dependent hypertonia) is one of the most common neuro-orthopaedic disorders following brain injury. It has a negative impact on walking and is closely linked to independence in activities of daily living.
This disorder combines a deficit in muscle strength in the plantar flexors and extensors with pathological hypertonia of the plantar flexors, causing an imbalance in ankle flexion and resulting in equinus deformity of the foot.
Botulinum toxin is the first-line pharmacological treatment for focal spasticity of neurological origin, and its effectiveness is directly linked to the quality and quantity of associated rehabilitation care. However, the associated rehabilitation protocols remain vague and are based on general recommendations combining: stretching of muscles and tendons, muscle strengthening of spastic muscles, their agonists and antagonists, and functional work. The standard rehabilitation protocol used in our centre will be detailed in the study protocol.
The isokinetic dynamometer is an open-chain muscle strengthening tool that has the advantage of introducing a concept of reproducible assessment and rehabilitation.
This reproducibility is difficult to guarantee with the rehabilitation techniques practised by a therapist, whose applied force and precision may vary from one session to another. We have therefore developed a sequential muscle strengthening protocol combining strengthening work - fatigue of the triceps surae followed by muscle strengthening work of the foot lifters.
The aim of this work is to determine the effects of this protocol compared to conventional rehabilitation aimed at promoting the post-injection effects of botulinum toxin.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patient
- •Patient with spastic hemiplegia (regardless of cause)
- •MAS 1-2 spasticity of the plantar flexors
- •Deficit of the foot lifters at the minimum stage of contraction with movement
- •Patient who has received botulinum toxin injections in the plantar flexors
- •Patient who has been informed about the research and has given their written and signed informed consent
- •Patient affiliated with a social security scheme or beneficiary of such a scheme
排除标准
- •Refusal of consent
- •Patient with severe cognitive impairment (MMSE <23/30)
- •Surgery on the affected lower limb
- •Patient unable to read, write or understand French
- •Patient who is pregnant or breastfeeding, in accordance with Article L1121-5 of the CSP
- •Vulnerable patients according to Article L1121-6 of the CSP
- •Adult patients under guardianship, curatorship or judicial protection
- •Patients unable to give their consent in person according to Article L.1121-8 of the CSP or adults protected by law
结局指标
主要结局
Strength of the foot lifters
时间窗: At the baseline, and after 1 month of rehabilitation course
The strength of the foot lifters will be assessed by the maximum peak torque of the foot lifters at 60° (rPT 60°) measured using an isokinetic dynamometer. The primary endpoint is the change in rPT 60° between the value at inclusion and the value at the end of rehabilitation. This endpoint will be compared between the two arms.
次要结局
- Peak torque resistance(At the baseline, after 1 month of rehabilitation course, after 3 month follow-up and after 6 month follow-up)
- rPT values(At the baseline, after 1 month of rehabilitation course , after 3 month follow-up and after 6 month follow-up)
- Measurement of the agonist/antagonist ratio(At the baseline, after 1 month of rehabilitation course , after 3 month follow-up and after 6 month follow-up)
- The distance covered during a 6-minute walk test and the walking speed measured during a 10-metre walk test at the various follow-up visits.(Before the rehabilitation protocol, during the consultation for the botulinum toxin injection, after 1 month of rehabilitation course, after 3 month follow-up and after 6 month follow-up)
- The spasticity score measured(Before the rehabilitation protocol, during the consultation for the botulinum toxin injection , after 1 month of rehabilitation course , after 3 month follow-up and after 6 month follow-up)
- The exercise tolerance score(Before the rehabilitation protocol, during the consultation for the botulinum toxin injection, after 1 month of rehabilitation course , after 3 month follow-up and after 6 month follow-up)
- Clinical improvement in spasticity,(After 3 month follow-up and after 6 month follow-up)
- Collect the number of adverse events(At the baseline, before the rehabilitation protocol, after 1 month of rehabilitation course, after 3 month follow-up and after 6 month follow-up)